Trials / Sponsors / Antengene Biologics Limited
Antengene Biologics Limited
Industry · 4 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Phase Ib/II Study of ATG-022 Plus Pembrolizumab With/Without Chemotherapy in Participants With Claudin (CLDN Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma | Phase 1 / Phase 2 | 2026-02-27 |
| Recruiting | A Study of ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas Advanced Solid Tumors, B-cell Non-Hodgkin Lymphomas | Phase 1 | 2023-12-08 |
| Recruiting | A Study of ATG-022 in Patients With Advanced/Metastatic Solid Tumors Advanced/Metastatic Solid Tumors | Phase 1 | 2023-03-27 |
| Terminated | A Study ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas Advanced Solid Tumor, Metastatic Solid Tumor, Mature B-cell Non-Hodgkin Lymphoma | Phase 1 | 2021-12-15 |